Given that HIF-1 activation in cancer cells induces substantial metabolic alterations that facilitate tumor growth and advancement (Infantino 2021), the potential for targeting the AMPK/HIF-1 pathway as a therapeutic approach in cancer treatment appears promising. Here, HIF1A is linked to cancer.